Aktien Sensor

Avantor Inc.’s stock price has surged to $13.19 USD, a significant increase from its 52-week low, following a push by an activist investor for strategic changes.

Terumo Corporation has acquired OrganOx, a UK-based medtech company, for $1.5 billion in a deal expected to strengthen its position in the medical technology sector, particularly in organ transplantation.

Sigma Healthcare Ltd reported revenue growth in its Q2 2025 earnings call, with its stock price closing at 3.04 AUD.

Eli Lilly’s stock price has surged by nearly 6% after its weight-loss medication, Orforglipron, met its primary goals in a Phase 3 trial, bringing it closer to regulatory approval.

Haleon PLC’s stock price has declined to a 52-week low, but analysts remain optimistic about the company’s long-term prospects due to its strong brand portfolio and commitment to innovation.

Dexcom Inc’s stock price declined by 6% after the company released its Q2 earnings, despite financial experts maintaining a strong buy rating due to its high growth potential.

Sonic Healthcare’s stock has plummeted 18% below its 52-week high, raising concerns about the company’s valuation and future prospects.

Eurofins Scientific SE’s stock price has declined due to broader market trends and European political uncertainty, but the company’s services in clinical diagnostics and digital biomarkers are expected to benefit from growing demand.

Astellas Pharma Inc’s market position is stable, with growth prospects driven by its focus on oncology and related therapeutic areas, particularly in androgen receptor-targeted therapies.

DiaSorin’s stock price surge is driven by a tug-of-war between Morgan Stanley’s optimistic rating and JPMorgan’s cautious assessment, highlighting the company’s growth potential versus its challenges.